Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Regeneron Pharmaceuticals Inc (REGN)  
$900.16 3.34 (0.37%) as of 4:30 Mon 4/22


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 104,690,000
Market Cap: 94.24(B)
Last Volume: 351,366 Avg Vol: 773,108
52 Week Range: $692.45 - $993.35
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    S&P COMPOSITE 1500     NASDAQ BIOTECHNOLOGY
    NASDAQ COMPOSITE     S&P SMALLCAP 600
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  150
Guru Rank Value     : 6.9
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Regeneron Pharmaceuticals is a biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Co.'s products include: EYLEA (aflibercept) Injection, which is used for the treatment of neovascular age-related macular degeneration, diabetic macular edema, macular edema following retinal vein occlusion, myopic choroidal neovascularization, diabetic retinopathy, and neovascular glaucoma; REGEN-COV, which is used for the treatment of COVID-19; and Kevzara (sarilumab) Solution for Subcutaneous Injection, which is used for the treatment of rheumatoid arthritis.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 44,242 84,942 123,521 283,828
Total Sell Value $42,199,254 $77,255,398 $109,380,071 $220,981,114
Total People Sold 10 13 15 17
Total Sell Transactions 22 38 55 116
End Date 2024-01-21 2023-10-20 2023-04-21 2022-04-21

   
Records found: 2400
  Page 1 of 96  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Mccourt Marion EVP Commercial   •       –      –    2024-04-01 4 AS $964.73 $241,183 D/D (250) 13,181 -7%     
   Ryan Arthur F Director   –       •      –    2024-04-01 4 AS $957.78 $96,253 D/D (100) 18,182 -7%     
   Murphy Andrew J EVP Research   •       –      –    2024-03-14 4 AS $951.92 $5,531,290 D/D (5,783) 48,306 -6%     
   Murphy Andrew J EVP Research   •       –      –    2024-03-13 4 D $971.82 $13,816,365 D/D (14,217) 54,089     -
   Murphy Andrew J EVP Research   •       –      –    2024-03-13 4 OE $399.66 $7,993,200 D/D 20,000 68,306     -
   Mccourt Marion EVP Commercial   •       –      –    2024-03-01 4 AS $967.50 $346,365 D/D (358) 13,431 -9%     
   Ryan Arthur F Director   –       •      –    2024-03-01 4 AS $967.50 $98,205 D/D (100) 18,282 -9%     
   Sing George L Director   –       •      –    2024-02-26 4 S $990.00 $992,500 D/D (1,000) 26,349 9%     
   Sing George L Director   –       •      –    2024-02-26 4 OE $413.33 $413,330 D/D 1,000 26,849     -
   Stahl Neil EVP Research and Development   •       –      –    2024-02-26 4 GD $0.00 $0 D/D 1,020 50,999     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2024-02-26 4 S $990.00 $990,000 D/D (1,000) 36,543 9%     
   Bassler Bonnie L Director   –       •      –    2024-02-26 4 S $979.25 $836,280 D/D (854) 1,382 9%     
   Bassler Bonnie L Director   –       •      –    2024-02-26 4 OE $391.92 $334,700 D/D 854 2,236     -
   Sing George L Director   –       •      –    2024-02-23 4 S $985.00 $492,500 D/D (500) 26,349 9%     
   Sing George L Director   –       •      –    2024-02-23 4 OE $413.33 $206,665 D/D 500 26,849     -
   Sing George L Director   –       •      –    2024-02-22 4 S $960.00 $2,895,000 D/D (3,000) 26,349 7%     
   Sing George L Director   –       •      –    2024-02-22 4 OE $413.33 $1,239,990 D/D 3,000 27,349     -
   Larosa Joseph J EVP General Counsel and Secret   •       –      –    2024-02-22 4 S $967.65 $967,650 D/D (1,000) 37,543 7%     
   Yancopoulos George Bd. Co-Chair, President & CSO   •       •      –    2024-02-15 4 D $953.83 $117,894,342 D/D (123,601) 801,608     -
   Yancopoulos George Bd. Co-Chair, President & CSO   •       •      –    2024-02-15 4 OE $399.66 $69,030,474 D/D 172,723 925,209     -
   Van Plew Daniel P EVP & General Mgr, Industrial   •       –      –    2024-02-14 4 S $937.94 $9,831,727 D/D (10,434) 20,378 5%     
   Van Plew Daniel P EVP & General Mgr, Industrial   •       –      –    2024-02-09 4 D $951.68 $23,735,851 D/D (24,941) 30,812     -
   Van Plew Daniel P EVP & General Mgr, Industrial   •       –      –    2024-02-09 4 OE $372.46 $13,382,510 D/D 35,375 47,153     -
   Fenimore Christopher R. SVP Finance & CFO   •       –      –    2024-02-09 4 S $950.49 $4,689,320 D/D (4,919) 14,372 6%     
   Sing George L Director   –       •      –    2024-02-09 4 S $955.00 $477,500 D/D (500) 26,349 6%     
  2400 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 96
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us